Three-Dimensional Bioconjugated Liquid-Like Solid (LLS) Enhance Characterization of Solid Tumor - Chimeric Antigen Receptor T cell interactions.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
21 Feb 2023
Historique:
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 4 3 2023
Statut: epublish

Résumé

Cancer immunotherapy offers lifesaving treatments for cancers, but the lack of reliable preclinical models that could enable the mechanistic studies of tumor-immune interactions hampers the identification of new therapeutic strategies. We hypothesized 3D confined microchannels, formed by interstitial space between bio-conjugated liquid-like solids (LLS), enable CAR T dynamic locomotion within an immunosuppressive TME to carry out anti-tumor function. Murine CD70-specific CAR T cells cocultured with the CD70-expressing glioblastoma and osteosarcoma demonstrated efficient trafficking, infiltration, and killing of cancer cells. The anti-tumor activity was clearly captured via longterm in situ imaging and supported by upregulation of cytokines and chemokines including IFNg, CXCL9, CXCL10, CCL2, CCL3, and CCL4. Interestingly, target cancer cells, upon an immune attack, initiated an "immune escape" response by frantically invading the surrounding microenvironment. This phenomenon however was not observed for the wild-type tumor samples which remained intact and produced no relevant cytokine response. Single cells collection and transcriptomic profiling of CAR T cells at regions of interest revealed feasibility of identifying differential gene expression amongst the immune subpopulations. Complimentary 3D in vitro platforms are necessary to uncover cancer immune biology mechanisms, as emphasized by the significant roles of the TME and its heterogeneity.

Identifiants

pubmed: 36865164
doi: 10.1101/2023.02.17.529033
pmc: PMC9980005
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001429
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA251978
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001427
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Clin Cancer Res. 2022 May 2;28(9):1759-1764
pubmed: 35046063
J Immunol. 2013 Jun 15;190(12):6673-80
pubmed: 23686489
Clin Cancer Res. 2017 May 1;23(9):2267-2276
pubmed: 27803044
Chin J Cancer. 2011 Mar;30(3):149-52
pubmed: 21352691
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
J Immunother Cancer. 2019 Mar 12;7(1):68
pubmed: 30867051
Semin Cancer Biol. 2005 Oct;15(5):378-86
pubmed: 15975825
Front Immunol. 2022 Feb 22;13:846346
pubmed: 35273619
Microbiol Immunol. 2022 May;66(5):201-211
pubmed: 35150167
Lancet. 2021 Jul 24;398(10297):314-324
pubmed: 34175021
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10101-6
pubmed: 18632580
J Immunol Methods. 2020 Dec;487:112899
pubmed: 33068606
Oncotarget. 2017 Aug 2;8(39):66137-66153
pubmed: 29029499
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nat Mater. 2012 Jul 01;11(8):734-41
pubmed: 22751180
Trends Cancer. 2020 Mar;6(3):181-191
pubmed: 32101722
Nat Rev Cancer. 2019 Jun;19(6):307-325
pubmed: 31092904
Stem Cells. 2015 Jun;33(6):1696-704
pubmed: 25694194
Blood Cancer J. 2021 Apr 6;11(4):69
pubmed: 33824268
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
Lancet. 2020 Sep 19;396(10254):839-852
pubmed: 32888407
Nat Genet. 2021 Sep;53(9):1275
pubmed: 34493863
Nat Methods. 2016 Apr 28;13(5):405-14
pubmed: 27123816
Nat Rev Mol Cell Biol. 2019 Dec;20(12):738-752
pubmed: 31582855
J Exp Med. 2019 May 6;216(5):1038-1049
pubmed: 30936262
Nat Protoc. 2020 Dec;15(12):4000-4033
pubmed: 33169003
Clin Cancer Res. 2019 Mar 15;25(6):1702-1708
pubmed: 30413526
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Front Immunol. 2021 Jun 29;12:689697
pubmed: 34267756
EBioMedicine. 2019 Feb;40:25-26
pubmed: 30665855
Stem Cell Res Ther. 2021 Jan 25;12(1):81
pubmed: 33494834
EMBO J. 2019 Jun 17;38(12):
pubmed: 31036555
J Vis Exp. 2018 Dec 12;(142):
pubmed: 30596389
Nat Commun. 2021 May 14;12(1):2815
pubmed: 33990566
Annu Rev Cell Dev Biol. 2016 Oct 6;32:469-490
pubmed: 27501447
Nat Med. 2015 May;21(5):524-9
pubmed: 25849134
Neuro Oncol. 2018 Jan 10;20(1):55-65
pubmed: 28651374
Cancer Res. 2005 Sep 1;65(17):7950-8
pubmed: 16140967
Nature. 2015 Mar 19;519(7543):366-9
pubmed: 25762141
J Cell Physiol. 2018 Apr;233(4):2993-3003
pubmed: 28618001
Exp Cell Res. 2011 Mar 10;317(5):620-31
pubmed: 21376175
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Cell Mol Immunol. 2020 Jun;17(6):570-575
pubmed: 32415259
Int J Cancer. 2017 Oct 1;141(7):1434-1444
pubmed: 28612394
Nat Methods. 2021 Jan;18(1):100-106
pubmed: 33318659
Blood. 2009 May 21;113(21):5167-75
pubmed: 19279334
Nat Biotechnol. 2014 Aug;32(8):760-72
pubmed: 25093883
Cancers (Basel). 2021 Jun 11;13(12):
pubmed: 34208323
Cancer Cell Int. 2015 Mar 18;15:31
pubmed: 25792975
J Immunol. 2002 Mar 15;168(6):2811-9
pubmed: 11884450
J Nanobiotechnology. 2022 Jan 10;20(1):30
pubmed: 35012567
Front Immunol. 2020 May 29;11:976
pubmed: 32547545
J Immunol Methods. 1977;18(1-2):123-32
pubmed: 915305
Adv Sci (Weinh). 2019 Sep 30;6(23):1901829
pubmed: 31832320
Nat Commun. 2019 Sep 5;10(1):4016
pubmed: 31488817
J R Soc Interface. 2020 Jan;17(162):20190734
pubmed: 31937234
Blood. 2003 Nov 1;102(9):3262-9
pubmed: 12855577
Clin Cancer Res. 2019 Feb 15;25(4):1142-1146
pubmed: 30309857
Methods. 2003 Oct;31(2):135-42
pubmed: 12957571
ACS Biomater Sci Eng. 2016 Oct 10;2(10):1787-1795
pubmed: 33440476
Science. 2022 Jan 07;375(6576):eabf9419
pubmed: 34990248
Cells. 2022 Mar 11;11(6):
pubmed: 35326418
Future Oncol. 2010 Dec;6(12):1863-81
pubmed: 21142861
Eur J Immunol. 1998 Aug;28(8):2331-43
pubmed: 9710211
JCI Insight. 2019 Sep 19;4(18):
pubmed: 31415244
Blood. 2011 Apr 21;117(16):4304-14
pubmed: 21304103
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Blood Adv. 2023 Feb 28;7(4):541-548
pubmed: 35938863
Cancer Immunol Immunother. 2021 Oct;70(10):2737-2750
pubmed: 33830275
EMBO Mol Med. 2017 Feb;9(2):137-153
pubmed: 28028012
Clin Cancer Res. 2014 Aug 15;20(16):4262-73
pubmed: 24919573
Adv Healthc Mater. 2019 Mar;8(5):e1900001
pubmed: 30734529
Cells. 2022 Jun 20;11(12):
pubmed: 35741103
Int Immunopharmacol. 2018 Oct;63:282-291
pubmed: 30121453
Proc Natl Acad Sci U S A. 2006 Jul 18;103(29):10889-94
pubmed: 16832052
Science. 2020 Mar 6;367(6482):
pubmed: 32139519
Neoplasia. 2022 Mar;25:18-27
pubmed: 35078134
J Clin Oncol. 2023 Jan 20;41(3):555-567
pubmed: 35658525
Sci Rep. 2018 Jan 9;8(1):199
pubmed: 29317736
BMC Cancer. 2013 Jul 31;13:367
pubmed: 23902851
Nat Rev Mater. 2020 Jul;5(7):539-551
pubmed: 32953138
Nat Biotechnol. 2014 Dec;32(12):1202-12
pubmed: 24880487
Nat Immunol. 2000 Nov;1(5):433-40
pubmed: 11062504
Science. 2020 Feb 28;367(6481):
pubmed: 32029687
Clin Cancer Res. 2020 Nov 1;26(21):5689-5700
pubmed: 32788225
Nature. 2022 Mar;603(7903):934-941
pubmed: 35130560
Cancer Res. 2011 Aug 15;71(16):5455-66
pubmed: 21715565

Auteurs

Duy T Nguyen (DT)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Ruixuan Liu (R)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Elizabeth Ogando-Rivas (E)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Alfonso Pepe (A)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Diego Pedro (D)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Sadeem Qdasait (S)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Nhi Tran Yen Nguyen (NTY)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Julia M Lavrador (JM)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Griffin R Golde (GR)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Ryan A Smolchek (RA)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.
UF Department of Pediatrics, Division of Pediatric Hematology Oncology, Gainesville, FL, 32610.
UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

John Ligon (J)

UF Department of Pediatrics, Division of Pediatric Hematology Oncology, Gainesville, FL, 32610.

Linchun Jin (L)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Haipeng Tao (H)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Alex Webber (A)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.
UF Department of Pediatrics, Division of Pediatric Hematology Oncology, Gainesville, FL, 32610.
UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Simon Phillpot (S)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.
UF Department of Pediatrics, Division of Pediatric Hematology Oncology, Gainesville, FL, 32610.
UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Duane A Mitchell (DA)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Elias J Sayour (EJ)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Jianping Huang (J)

UF Brain Tumor Immunotherapy Program, Lillian S. Wells Department of Neurosurgery, Preston A. Wells, Jr. Center for Brain Tumor Therapy, McKnight Brain Institute, University of Florida, 1149 South Newell Drive, Gainesville, FL, 32611, USA.

Paul Castillo (P)

UF Department of Pediatrics, Division of Pediatric Hematology Oncology, Gainesville, FL, 32610.

W Gregory Sawyer (WG)

UF Department of Mechanical and Aerospace Engineering, Gainesville, FL, 32610.

Classifications MeSH